frogman's picture
frogman
  • 5
560

recently I read a article about EPO, share with u guys.

ad

INTRODUCTION: These guidelines approximate the criteria from the large controlled trials of recombinant
human erythropoietin (r-Hu-EPO) in preterm infants. For other situations in which r-Hu-EPO may be useful
(e.g., severe BPD, late anemia after intrauterine transfusion), consult with the Neonatology Fellow, Attending
Physician, Dr. Roderic Phibbs or Dr. Kevin Shannon (Division of Pediatric Hematology/Oncology).

CRITERIA:
1. Any infant with birth weight ≤1,250 g and gestation <31 weeks who has all of the following:
(a) Total caloric intake ≥ 50 kcal/kg/d, of which at least half is enteral
(b) Hematocrit (Hct) <40% or 40-50% but falling 2% per day
(c) Mean airway pressure <11 cmH2O and FIO2 <0.40
(d) Postnatal age >6d and gestational age <33 weeks
2. Any infant with birth weight 1,251-1,500 g and phlebotomy losses >5 mL/kg/week who meet criteria (a)
through (d) above

EXCLUSIONS: Major anomalies, dysmorphic syndromes, hemolytic anemia, active major infection.

DOSE AND DURATION: 750 u/kg/week subcutaneously divided into three doses QOD (e.g., 250 u/kg on
Mon, Wed, Fri). Discontinue r-Hu-EPO when infant reaches 34 weeks gestational age. (Multiple patients
can be treated using the same vial of r-Hu-EPO.)

IRON: Start oral iron at 2 mg/kg/d as soon as tolerated and increase to 4 mg/kg/d when feeds reach 100
mL/kg. If not on iron after 2 weeks of r-Hu-EPO treatment, consult with Dr. Shannon or Dr. Phibbs.

Consider:
1. Intravenous iron (1 mg/kg/d in intravenous alimentation fluid) or
2. Discontinue r-Hu-EPO.
When at full feeds, start UCSF preterm vitamins (see section on Vitamins, P. 55).
MONITORING OF R-Hu-EPO THERAPY:
•Measure Hct and reticulocyte count weekly.
•Reticulocyte count should reach 200,000 after 1-2 weeks of treatment with r-Hu-
EPO.
•If Hct reaches 45% without transfusion, discontinue r-Hu-EPO, and consult with Dr.
Shannon or Phibbs before restarting.

POST THERAPY: Hct and reticulocyte count will decline. EndogenousEPO will be
released only when the infant becomes anemic (usually at Hct in the mid 20s). Only then
will reticulocytes rise again. If reticulocyte count has not started to rise at the time of the
infant’s discharge, alert the primary MD to the need to follow the Hct and reticulocyte
count.